Sunday, 20 September 2026European Markets

NEXT BIOMETRICS GP Stock Went Up By Over 27% In The Last 21 Sessions

Loading stream...

(VIANEWS) - Shares of NEXT BIOMETRICS GP (Oslo Børs Benchmark Index_GI: NEXT.OL) rose by a staggering 27.92% in 21 sessions from kr4.19 to kr5.36 at 15:10 EST on Thursday, after two successive sessions in a row of losses. Oslo Børs Benchmark Index_GI is jumping 0.31% to kr1,207.72, following the last session's upward trend.

NEXT BIOMETRICS GP's last close was kr5.40, 9.7% below its 52-week high of kr5.98.

About NEXT BIOMETRICS GP

NEXT Biometrics Group ASA, through its subsidiaries, engages in the research, development, manufacture, and commercialization of fingerprint technology and products in Asia. The company offers fingerprint sensor modules and readers, flexible biometric subassemblies, and face recognition software, as well as software and hardware development kits for USB and SPI modules. Its products are used in point of sales terminals, smart card, government ID, access control, internet of things, and notebook applications. The company sells its sensors to distributors of electronic components. NEXT Biometrics Group ASA was incorporated in 2001 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, NEXT BIOMETRICS GP has a trailing twelve months EPS of kr-0.5.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -40.24%.

More news about NEXT BIOMETRICS GP (NEXT.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com